Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNEUMOSTEM Phase II Follow-up in BPD
NCT04003857Phase 2Active, not recruiting
- Sponsor
- MEDIPOST
- Start
- Jul 2019
- Primary completion
- Jun 2027
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing PNEUMOSTEM with Placebo (2 arms). Primary endpoint: Number of hospitalizations (Respiratory outcome). Started Jul 2019; status: active, not recruiting.
02
Drugs
pneumostem
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT04003857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003857.